Question: Did Holst's ten-year-old daughter have any siblings? Passage 1:When Joseph left Girton, the First World War was at a critical state; the Battle of the Somme had begun on 1 July 1916. Joseph wanted to assist the war effort, and after considering work on the land or in a munitions factory, took up part-time welfare work in Islington. In the autumn of 1916 she began teaching at Eothen, a small private school for girls in Caterham, founded and run by the Misses Catharine and Winifred Pye. In 1917 Holst's ten-year-old daughter Imogen started at the school; soon, under Joseph's guidance the young pupil was composing her own music. Joseph extended her own musical activities by joining the orchestra at Morley College, where Holst was the director of music and where her brother Edwin had played the cello before the war. At first she played the double-bass, but later took French horn lessons, possibly from Adolph Borsdorf; later still, at very short notice, she taught herself the timpani part for a summer concert. By 1918 she was a member of the Morley committee that on 9 March organised and produced an opera burlesque, English Opera as She is Wrote, in which English, Italian, German, French and Russian opera styles were parodied in successive scenes. The performance was a great success and was repeated at several venues. It may have inspired Holst to use parody in his own opera, The Perfect Fool, which he began composing in 1918. In her spare time Joseph founded and ran a choir for Kensington nannies, which took part in local singing contests as the "Linden Singers".
 Passage 2:He was principal investigator on the REFLECT trial for flosequinan which ran from 1987-1989 and the following PROFILE trial from 1991-1994. He was PI on a study of amlodipine that ran from 1987-1989 and the following PRAISE trial from 1992-1995 and PRAISE 2 from 1996-1999; the PROMISE trial for milrinone 1988-1990; the ATLAS trial for lisinopril from 1993-1997; the PRECISE trial for carvedilol from 1993-1995 and the following COPERNICUS trial from 1997-2002; the ENABLE trial (1999-2001) and REACH-1 trial (1997-2003) for bosentan; the OVERTURE trial (1999-2002) for omapatrilat; REVIVE I and II (2001-2006) for levosimendan; and the TRUE-AHF trial of ularitide that started in 2013. He also chaired the steering committee for the RADIANCE trial from 1989-1992 which studied the use of digoxin in people who were also treated with ACE inhibitors and chaired the steering committee for the RENEWAL trial (1999-2002) for etanercept. He was also the co-PI of the PARADIGM-HF trial that led to the approval of valsartan/sacubitril.
 Passage 3:The Tampa Bay Rays selected Faria in the 10th round of the 2011 Major League Baseball draft. He made his professional debut with the Gulf Coast Rays. Faria played 2012 and 2013 with the Princeton Rays. He pitched 2014 with the Bowling Green Hot Rods and started 2015 with the Charlotte Stone Crabs. After going 10–1 with a 1.33 earned run average (ERA) in 12 games, he was promoted to the Double-A Montgomery Biscuits. In his second start with Montgomery tied a team record with 14 strikeouts over seven no-hit innings. Faria started 2016 with Montgomery and was called to the Durham Bulls in June. Entering the 2017 Season, Faria was considered by Baseball America to be the 8th best prospect in the Rays farm system.. He started the season with the Bulls, and was promoted to the Rays on June 6.

Output: 1